Andrea A Zachary
Overview
Explore the profile of Andrea A Zachary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Redfield R, Jordan S, Busque S, Vincenti F, Woodle E, Desai N, et al.
Am J Transplant
. 2019 Jul;
19(11):3035-3045.
PMID: 31257724
The limited effectiveness of rituximab plus intravenous immunoglobulin (IVIG) in desensitization may be due to incomplete B cell depletion. Obinutuzumab is a type 2 anti-CD20 antibody that induces increased B...
2.
Montgomery R, Tatapudi V, Leffell M, Zachary A
Nat Rev Nephrol
. 2018 Jul;
14(9):558-570.
PMID: 29985463
The human major histocompatibility complex is a family of genes that encodes HLAs, which have a crucial role in defence against foreign pathogens and immune surveillance of tumours. In the...
3.
Pinelli D, Zachary A, Friedewald J, Gjertson D, Evans M, Chatroop E, et al.
Am J Transplant
. 2018 Jul;
19(2):381-390.
PMID: 29981209
Currently, the ability to predict or monitor the efficacy of HLA antibody-removal therapies is deficient. We previously reported that titration studies are a consistent and accurate means of assessing antibody...
4.
Philogene M, Zhou S, Lonze B, Bagnasco S, Alasfar S, Montgomery R, et al.
Hum Immunol
. 2018 Feb;
79(4):195-202.
PMID: 29428484
Retrospective studies of angiotensin II type 1 receptor antibodies (AT1R-Ab) and anti-endothelial cell antibodies (AECA) have linked these antibodies to allograft injury. Because rising healthcare costs dictate judicious use of...
5.
Zachary A, Leffell M
Curr Opin Organ Transplant
. 2017 Jun;
22(4):398-399.
PMID: 28632700
No abstract available.
6.
Zachary A, Leffell M
Front Immunol
. 2016 Dec;
7:575.
PMID: 28003816
HLA matching provides numerous benefits in organ transplantation including better graft function, fewer rejection episodes, longer graft survival, and the possibility of reduced immunosuppression. Mismatches are attended by more frequent...
7.
Philogene M, Bagnasco S, Kraus E, Montgomery R, Dragun D, Leffell M, et al.
Transplantation
. 2016 May;
101(3):608-615.
PMID: 27222934
Background: This is a cross-sectional study designed to evaluate the histologic characteristics of graft injury in the presence of anti-angiotensin II type 1 receptor antibody (AT1R-Ab) and anti-endothelial cell antibody...
8.
Bettinotti M, Zachary A, Leffell M
Curr Opin Organ Transplant
. 2016 May;
21(4):453-8.
PMID: 27200498
Purpose Of Review: Accurate and timely detection and characterization of human leukocyte antigen (HLA) antibodies are critical for pre-transplant and post-transplant immunological risk assessment. Solid phase immunoassays have provided increased...
9.
Lipson E, Bagnasco S, Moore Jr J, Jang S, Patel M, Zachary A, et al.
N Engl J Med
. 2016 Mar;
374(9):896-8.
PMID: 26962927
No abstract available.
10.
Young R, Dale B, Russell S, Zachary A, Tedford R
Clin Transplant
. 2015 May;
29(8):685-8.
PMID: 25982351
Background: In cardiac transplant recipients, the development of antibodies to the endothelial intermediate filament protein vimentin (antivimentin antibodies, AVA) has been associated with rejection and poor outcomes. However, the incidence...